entertainment -WSS

entertainment

author：leisure time 2025-09-30 17:28:41 - browse：22471

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： ‘Oppenheimer’ and the risks of AI in health care

WSS

5 important ways Henrietta Lacks changed medical science

‘Oppenheimer’ and the risks of AI in health care

The high personal cost of affirmative action for Black doctors

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Scientists inch closer to single

Adults seen as increasingly susceptible to measles

hotspot

entertainment

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Scientists inch closer to single

As demand for Covid shots wanes, Moderna seeks its next success

CRISPR pioneers react to Casgevy, first gene

Wildfire smoke exposes gaps in outdoor worker protections

Astellas still sees hope in its gene therapy after four deaths

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Astellas still sees hope in its gene therapy after four deaths

Virginia high school admissions case could be legal follow

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

entertainment

Hospitals look to new technology to keep health care workers safe

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

‘Oppenheimer’ and the risks of AI in health care

In key trial, Verve's treatment lowers cholesterol levels in patients

NIH launches clinical trials and new research office for long Covid

Why medical students are struggling with mental health

knowledge

hotspot

entertainment

explore